Munich - Delayed Quote • EUR Cipher Pharmaceuticals Inc (PHE.MU) Follow 5.85 0.00 (0.00%) At close: April 26 at 8:03 AM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PHE.MU 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PHE.MU View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cipher Pharmaceuticals Inc.'s (TSE:CPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference Cipher Pharmaceuticals' (TSE:CPH) three-year earnings growth trails the 93% YoY shareholder returns Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX Cipher Pharmaceuticals Announces Change of Auditor Cipher Pharmaceuticals Announces Normal Course Issuer Bid Cipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insiders Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023 Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call
